Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2022-08-05 00:00:00 ET · period of report 2022-08-03 · accession 0001735276-22-000065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-05 | 2022-08-04 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | F - Tax | $191.55 | -5,086 | 17.9K | -22% | -$974.2K |
| M | 2022-08-05 | 2022-08-03 | ALNY | Garg Pushkal | CMO, EVP Dev, Med Affairs | A - Grant | $0.00 | +11.3K | 15.7K | +257% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-04 | F | D | 146 | $210.02 | 17,417 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-04 | F | D | 172 | $209.91 | 17,563 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-04 | F | D | 165 | $205.87 | 17,735 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-03 | A | A | 3,109 | $0.00 | 22,503 | D | — | — | |
| 5 | Common | Common Stock | 2022-08-03 | A | A | 3,684 | $0.00 | 19,394 | D | — | — | |
| 6 | Common | Common Stock | 2022-08-03 | A | A | 4,518 | $0.00 | 15,710 | D | — | — | |
| 7 | Common | Common Stock | 2022-08-04 | F | D | 4,603 | $189.76 | 17,900 | D | — | — |